市场概况

External ventricular drainage provides a valuable minimally invasive solution for treating acute hydrocephalus and other conditions necessitating cerebrospinal fluid diversion. As a temporary measure, EVDs are placed directly into the brain’s ventricles to drain excess CSF until stable reabsorption is restored.

Current market forecasts anticipate continued strong growth in EVD systems adoption over the coming years. A projected compound annual growth rate exceeding 7.8 percent reflects intensifying clinical needs as neurosurgery techniques advance and global disease burdens mount. Rates of hydrocephalus especially are considerable, impacting millions worldwide annually.

As a medical emergency, hydrocephalus presents serious risks such as elevated intracranial pressure susceptible to further neurological injury if untreated. Prompt CSF drainage through EVD placement is therefore paramount to stabilize patients for additional shunt or management procedures. Expanding access to care even in underserved regions will be key to making these lifesaving interventions more widely available.

Beyond hydrocephalus specifically, EVDs may also benefit head trauma, aneurysm and tumor resection patients experiencing intraventricular hemorrhage or edema. Their integration into post-surgical critical care pathways improves recovery outcomes. Streamlined multi-lumen catheters simplify simultaneous monitoring and drainage while protecting delicate ventricular ependyma from abrasion or occlusion.

From a technological perspective, biomaterials science continues yielding ever more bioabsorbable and anti-migrational materials lessening device complications. Nanocoatings that prevent clogging and infection could further expand applications to chronic settings. Overall market prospects appear bright as user-friendly EVD design and care delivery optimization enhance the quality and efficiency of complex neurosurgical cases.

市场细分

该行业报告提供了全球市场的市场估计和预测, 接下来是对应用的详细分析, 患者组, 和地理.
应用: intracerebral brain hemorrhage (我), 蛛网膜下腔出血, 创伤性脑损伤 (脑外伤性脑损伤), 其他的
Patient group: 小儿, 成人
地理: 北美, 欧洲, 亚太地区, 中东和非洲, 拉美

Analyzing by application, 创伤性脑损伤 (脑外伤性脑损伤) accounted for the dominant share of 38.1% of total market revenue in 2022. This segment is poised to chart the fastest expansion over the forecast period as well.

The rising incidence of TBI worldwide is the predominant factor driving acute EVD adoption. Per estimates, 超过 60 million new cases of TBI arising from falls, accidents and assaults are recorded annually across the globe.

TBI often leads to accumulation of excess cerebrospinal fluid in the brain due to hematomas or edema, heightening intracranial pressure. Acute EVD catheters provide crucial intervention by draining this fluid to stabilize patients. Usage helps mitigate secondary brain injury from elevated pressure, enabling recovery.

Based on geography, North America held the leading 35.6% 市场份额 2021. Dominance of North America stems from the high prevalence of neurological conditions like hemorrhagic and ischemic strokes, 脑积水, tumors requiring EVD intervention.

Established healthcare access and infrastructure also advantage the region, with specialized neuro-critical care units equipped with the latest technology. Reimbursement coverage for emergency neurosurgery procedures further propagates acute EVD placements. The U.S. remains at the epicenter of progress, with advanced new EVD devices receiving FDA approvals to meet evolving clinical needs.

Asia Pacific is forecast to grow at the most rapid clip globally, riding tailwinds like expanding healthcare expenditure, patient pool and neurosurgery infrastructure. Specifically China, Japan and India will present considerable opportunities as investment flows into facilities and equipment modernization.

主要公司及竞争格局

The market research report covers the analysis of key stake holders of the global acute EVD market. Some of the leading players profiled in the report include Fuji Systems Corporation, Integra生命科学控股公司, 美敦力公司, 内特斯医疗公司, Neuromedex GmbH, Sophysa SA, 斯皮格尔伯格有限公司 & 钴. 公斤, 除其他外. 在这份报告中, 全面分析关键参与者及其策略，以了解市场的竞争前景.

报告范围

To analyze and forecast the market size of the global acute EVD market.
To classify and forecast the global acute EVD market based on application, 患者组, 地理.
To identify drivers and challenges for the global acute EVD market.
检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global acute EVD market.
To identify and analyze the profile of leading players operating in the global acute EVD market.

为什么选择这份报告

Gain a reliable outlook of the global acute EVD market forecasts from 2023 到 2029 跨场景.
确定投资的增长领域.
通过公司简介和市场数据领先于竞争对手.
Excel 格式的跨场景分析易用性的市场预估.
三个月的战略咨询和研究支持.
为单用户许可证提供打印验证.